Clinical Trials

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms

NCT06349642 2026-03-12

ELEPHAS-04

Recruiting

324 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinosarcoma, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07466901 2026-03-12

A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer

30 enrolled

Uterine Cervical Neoplasms

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

24 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT07461818 2026-03-11

POC

5,000 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections

NCT04341883 2026-03-10

Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

Phase 2 Completed

27 enrolled

Uterine Cervical Neoplasms

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

5 enrolled

Uterine Cervical Neoplasms

NCT05824468 2026-03-10

Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer

30 enrolled

Uterine Cervical Neoplasms

NCT06142760 2026-03-09

AIM-C1

40 enrolled

Uterine Cervical Neoplasms

NCT00188539 2026-03-06

Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels

346 enrolled

Uterine Cervical Neoplasms

NCT00900575 2026-03-06

Cervical Cancer Detection Using Optical Spectroscopy

350 enrolled

Uterine Cervical Neoplasms

NCT00957450 2026-03-06

Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging

Active not recruiting

12 enrolled

Uterine Cervical Neoplasms

NCT04107181 2026-03-06

Calla

305 enrolled

Uterine Cervical Neoplasms

NCT04423679 2026-03-06

SELFIE

Completed

294 enrolled

Uterine Cervical Neoplasms

NCT07453459 2026-03-06

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

100 enrolled

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT03853915 2026-03-05

HPVDNA02

64 enrolled

Uterine Cervical Neoplasms

NCT04723095 2026-03-05

NeCTuR

Recruiting

750 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms

NCT05035173 2026-03-04

LYSA

Phase NA Completed

200 enrolled

BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT07447895 2026-03-04

Early Pelvic Floor Physical Therapy for Women Undergoing Pelvic Radiation for Gynecologic Malignancies

28 enrolled

Uterine Cervical Neoplasms, Pelvic Floor Disorders

NCT06968871 2026-03-03

Ameliorated Pap Tests and Cervical Cancer Screening Participation

248 enrolled

Uterine Cervical Neoplasms, Pain

NCT07372248 2026-03-02

Thermal Artifact in Patients Undergoing Conization: A Clinical Study

150 enrolled

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT05063916 2026-02-27

Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix

18 enrolled

GastrointestinalGenitourinaryGynecologicHead & Neck

Carcinoma, Uterine Cervical Neoplasms

NCT05639972 2026-02-27

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Phase 1/2 Recruiting

15 enrolled

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT07428330 2026-02-27

CASCADE3001A

1,600 enrolled

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07435376 2026-02-27

INTLECTUAL

Phase 2 Recruiting

17 enrolled

Carcinoma, Squamous Cell, Uterine Cervical Neoplasms

NCT07439497 2026-02-27

DEHIM_CCRT

Phase 2 Recruiting

34 enrolled

Uterine Cervical Neoplasms

NCT05581121 2026-02-25

PAROLA

Phase 3 Recruiting

510 enrolled

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

NCT07225530 2026-02-25

(iSTAR)

600 enrolled

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT07406087 2026-02-25

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcoma

25 enrolled

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Testicular Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT07433283 2026-02-25

Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

Phase 1/2 Recruiting

54 enrolled

GastrointestinalGynecologicHead & NeckThoracic

Uterine Cervical Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Thyroid Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms

NCT06263283 2026-02-24

KYOCOL

Phase NA Active not recruiting

98 enrolled

Uterine Cervical Neoplasms

NCT05334706 2026-02-23

RIFT-HPV

Phase 4 Recruiting

69 enrolled

Uterine Cervical Neoplasms, Infections, Papillomavirus Infections, Squamous Intraepithelial Lesions of the Cervix

NCT07209917 2026-02-23

ASHA-Health II

420 enrolled

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms, Infections, Papillomavirus Infections

NCT04065269 2026-02-20

ATARI

174 enrolled

GynecologicSarcoma

Carcinosarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT07294066 2026-02-20

Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina

112 enrolled

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms

NCT07424664 2026-02-20

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

30 enrolled

Uterine Cervical Neoplasms, Neoplasm Metastasis, Recurrence, Vaginal Neoplasms, Vulvar Neoplasms

NCT05413811 2026-02-17

ACT2

Phase NA Completed

180 enrolled

Phase 4 Not yet recruiting

Acquired Immunodeficiency Syndrome, Uterine Cervical Neoplasms

NCT07412873 2026-02-17

PROVIDENCE

120 enrolled